21 Novembre 2026

Psicologia Punto One | Psicologia e Psicologi nel Web

Menu

Menu

SCHEDA SCIENTIFICA2026Studio randomizzato

Phase 3 randomized trial of latozinemab in frontotemporal dementia due to GRN mutations.

Adam Simmons, Bradley Boeve, Isabelle Le Ber, Barbara Borroni, Catherine Mummery, Jonathan D Rohrer, Giovanna Zamboni, Oezguer A Onur, James B Rowe, Adam L Boxer, Tina Schwabe, Olga I Kahn, Julie Y Huang, Hua Long, Ruchi Gupta, Jinglin Zhong, Caiyan Li, Leonard Guizzetti, Lawrence P Carter, Tuan Nguyen, Tiffany W Chow, Balasubrahmanyam Budda, Lovingly Park, Sam Jackson, Robert Paul, Michael Ward, Gary Romano, Sara Kenkare-Mitra, Arnon Rosenthal, Giacomo Salvadore, Arthur J Mayorga

Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026

Abstract e pubblicazione originale

L’abstract è consultabile nella fonte originale. Non viene ripubblicato qui perché non risulta verificata una licenza compatibile.

Leggi nella fonte originale ↗

Parole chiave

HumansProgranulinsFrontotemporal DementiaDouble-Blind MethodMaleMutationFemaleAgedMiddle AgedAntibodies, MonoclonalIntercellular Signaling Peptides and ProteinsTreatment OutcomeBiomarkersAntibodies, Monoclonal, HumanizedGRN mutationdisease‐modifying therapyfrontotemporal dementiageneticglial fibrillary acidic protein (GFAP)latozinemabneurofilament light chain (NfL)phase 3 clinical trialprogranulinsortilin

Come citare questo studio

Adam Simmons, Bradley Boeve, Isabelle Le Ber, Barbara Borroni, Catherine Mummery, Jonathan D Rohrer, Giovanna Zamboni, Oezguer A Onur, James B Rowe, Adam L Boxer, Tina Schwabe, Olga I Kahn, Julie Y Huang, Hua Long, Ruchi Gupta, Jinglin Zhong, Caiyan Li, Leonard Guizzetti, Lawrence P Carter, Tuan Nguyen, Tiffany W Chow, Balasubrahmanyam Budda, Lovingly Park, Sam Jackson, Robert Paul, Michael Ward, Gary Romano, Sara Kenkare-Mitra, Arnon Rosenthal, Giacomo Salvadore, Arthur J Mayorga. (2026). Phase 3 randomized trial of latozinemab in frontotemporal dementia due to GRN mutations.. Alzheimer's & dementia : the journal of the Alzheimer's Association. DOI: 10.1002/alz.71947

Consulta la pubblicazione originale ↗